|

Everolimus 5 MG Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • AC Camargo Cancer Center1

Indications

  • Neuroendocrine Tumor Carcinoid1
  • Neuroendocrine Tumor of the Lung1
  • Neuroendocrine Tumor of Pancreas1
  • Progression1
  • Neuroendocrine Tumor Grade 21

Other1 trial

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.